Status:
COMPLETED
Improving Adherence in Patients With Hypertension - A Novel Use of Communication Technology
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Hypertension
Eligibility:
All Genders
45-65 years
Phase:
NA
Brief Summary
Treating hypertension is known to decrease morbidity and mortality. Despite this 70% of patients do not have adequately controlled blood pressure. The main reason for this is non-adherence to recommen...
Eligibility Criteria
Inclusion
- Prescription of a once-a-day dose of atenolol.
- Morisky Score of less than or equal to 2 (explanation in 'Equitable Selection of Subjects').
- Fluency in English.
- Age 45-65 inclusive.
- Primary Care Physician consent to the patient taking part.
Exclusion
- Patients prescribed more than two anti-hypertensive agents.
- Patients prescribed more than four medications in total.
- Patients on secondary prevention following cardiac event or stroke.
- Morisky Score of more than 2.
- Patients with visual impairment or color-blindness.
- Patients with congenital or acquired cognitive impairment.
- Patients with a cardiac pacemaker
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT00277381
Start Date
July 1 2006
End Date
January 1 2008
Last Update
March 1 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114